Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast.

Vranic S, Senarathne W, Stafford P, Poorman K, Pockaj BA, Gatalica Z.

Appl Immunohistochem Mol Morphol. 2019 Sep 11. doi: 10.1097/PAI.0000000000000808. [Epub ahead of print]

PMID:
31517642
2.

Changing Trends in the Referral and Timing of Treatment for Congenital Cryptorchidism: A Single-Center Experience from Bosnia and Herzegovina.

Zvizdic Z, Islamovic B, Milisic E, Jonuzi A, Vranic S.

J Pediatr Surg. 2019 Aug 29. pii: S0022-3468(19)30552-4. doi: 10.1016/j.jpedsurg.2019.08.013. [Epub ahead of print]

PMID:
31500876
3.

Letter to editor/comment.

Vranic S.

Breast J. 2019 Jul 28. doi: 10.1111/tbj.13469. [Epub ahead of print] No abstract available.

PMID:
31353784
4.

Decreases in Iron Oxide Reducibility during Microbial Reductive Dissolution and Transformation of Ferrihydrite.

Aeppli M, Vranic S, Kaegi R, Kretzschmar R, Brown AR, Voegelin A, Hofstetter TB, Sander M.

Environ Sci Technol. 2019 Aug 6;53(15):8736-8746. doi: 10.1021/acs.est.9b01299. Epub 2019 Jul 24.

PMID:
31339302
5.

Graphene oxide as a 2D platform for complexation and intracellular delivery of siRNA.

de Lázaro I, Vranic S, Marson D, Rodrigues AF, Buggio M, Esteban-Arranz A, Mazza M, Posocco P, Kostarelos K.

Nanoscale. 2019 Aug 7;11(29):13863-13877. doi: 10.1039/c9nr02301a. Epub 2019 Jul 12.

PMID:
31298676
6.

Immunohistochemistry-Enabled Precision Medicine.

Gatalica Z, Feldman R, Vranić S, Spetzler D.

Cancer Treat Res. 2019;178:111-135. doi: 10.1007/978-3-030-16391-4_4.

PMID:
31209843
7.

Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer.

Sareyeldin RM, Gupta I, Al-Hashimi I, Al-Thawadi HA, Al Farsi HF, Vranic S, Al Moustafa AE.

Cancers (Basel). 2019 May 10;11(5). pii: E646. doi: 10.3390/cancers11050646. Review.

8.

Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.

Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, Sheng S.

PLoS One. 2019 Apr 19;14(4):e0215089. doi: 10.1371/journal.pone.0215089. eCollection 2019.

9.

Graphene Oxide Flakes Tune Excitatory Neurotransmission in Vivo by Targeting Hippocampal Synapses.

Rauti R, Medelin M, Newman L, Vranic S, Reina G, Bianco A, Prato M, Kostarelos K, Ballerini L.

Nano Lett. 2019 May 8;19(5):2858-2870. doi: 10.1021/acs.nanolett.8b04903. Epub 2019 Apr 18.

PMID:
30983361
10.

Letter to the Editor/Response.

Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S.

Breast J. 2019 May;25(3):569. doi: 10.1111/tbj.13284. Epub 2019 Apr 13. No abstract available.

PMID:
30980590
11.

Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer.

Cyprian FS, Akhtar S, Gatalica Z, Vranic S.

Bosn J Basic Med Sci. 2019 Aug 20;19(3):227-233. doi: 10.17305/bjbms.2019.4204. Review.

12.

Laparoscopic Extirpation of Adrenal Gland Ganglioneuroma Incidentally Diagnosed During Evaluation for Patchy Alopecia Areata in an Adolescent Boy.

Zvizdic Z, Haxhija E, Chikha A, Milisic E, Jonuzi A, Vranic S.

Med Princ Pract. 2019 Mar 22. doi: 10.1159/000499755. [Epub ahead of print]

13.

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity.

Gupta I, Sareyeldin RM, Al-Hashimi I, Al-Thawadi HA, Al Farsi H, Vranic S, Al Moustafa AE.

Cancers (Basel). 2019 Mar 13;11(3). pii: E363. doi: 10.3390/cancers11030363. Review.

14.

Toxicological Evaluation of SiO₂ Nanoparticles by Zebrafish Embryo Toxicity Test.

Vranic S, Shimada Y, Ichihara S, Kimata M, Wu W, Tanaka T, Boland S, Tran L, Ichihara G.

Int J Mol Sci. 2019 Feb 18;20(4). pii: E882. doi: 10.3390/ijms20040882.

15.

Gastric Necrosis and Perforation Following Massive Gastric Dilatation in an Adolescent Girl: A Rare Cause of Acute Abdomen.

Zvizdic Z, Jonuzi A, Djuran A, Vranic S.

Front Surg. 2019 Jan 30;6:3. doi: 10.3389/fsurg.2019.00003. eCollection 2019.

16.

Encysted hydrocele of the canal of Nuck in an 11-month-old child with a past history of duodenal atresia and Arnold-Chiari malformation: A case report.

Zvizdic Z, Milisic E, Chikha A, Sefic I, Dzananovic A, Vranic S.

Medicine (Baltimore). 2019 Jan;98(4):e14232. doi: 10.1097/MD.0000000000014232.

17.

Teucrium Polium Plant Extract Provokes Substantial Cytotoxicity at the Early Stage of Embryonic Development.

Al-Qahdi SS, Alzohari N, Alsaid AY, Ashour AA, Aboulkassim T, Vranic S, Al Moustafa AE, Khalil AA.

Bosn J Basic Med Sci. 2019 Feb 12;19(1):67-71. doi: 10.17305/bjbms.2018.4052.

18.

Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast.

Vranic S, Palazzo J, Swensen J, Xiu J, Florento E, Gatalica Z.

Breast J. 2019 Jan;25(1):175-176. doi: 10.1111/tbj.13187. Epub 2018 Dec 18. No abstract available.

PMID:
30565349
19.

Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.

Terlević R, Perić Balja M, Tomas D, Skenderi F, Krušlin B, Vranic S, Demirović A.

Ann Diagn Pathol. 2019 Feb;38:62-66. doi: 10.1016/j.anndiagpath.2018.11.002. Epub 2018 Nov 20.

PMID:
30476894
20.

Water-pipe smoking promotes epithelial-mesenchymal transition and invasion of human breast cancer cells via ERK1/ERK2 pathways.

Sadek KW, Haik MY, Ashour AA, Baloch T, Aboulkassim T, Yasmeen A, Vranic S, Zeidan A, Al Moustafa AE.

Cancer Cell Int. 2018 Nov 13;18:180. doi: 10.1186/s12935-018-0678-9. eCollection 2018.

21.

Small, Thin Graphene Oxide Is Anti-inflammatory Activating Nuclear Factor Erythroid 2-Related Factor 2 via Metabolic Reprogramming.

Hoyle C, Rivers-Auty J, Lemarchand E, Vranic S, Wang E, Buggio M, Rothwell NJ, Allan SM, Kostarelos K, Brough D.

ACS Nano. 2018 Dec 26;12(12):11949-11962. doi: 10.1021/acsnano.8b03642. Epub 2018 Nov 20.

PMID:
30444603
22.

Epstein-Barr virus (EBV) status in colorectal cancer: a mini review.

Bedri S, Sultan AA, Alkhalaf M, Al Moustafa AE, Vranic S.

Hum Vaccin Immunother. 2019;15(3):603-610. doi: 10.1080/21645515.2018.1543525. Epub 2018 Nov 15.

PMID:
30380978
23.

Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.

Vranic S, Palazzo J, Sanati S, Florento E, Contreras E, Xiu J, Swensen J, Gatalica Z.

Clin Breast Cancer. 2019 Apr;19(2):131-136. doi: 10.1016/j.clbc.2018.09.001. Epub 2018 Sep 5.

24.

Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia.

Kurtovic-Kozaric A, Vranic S, Kurtovic S, Hasic A, Kozaric M, Granov N, Ceric T.

J Glob Oncol. 2018 Sep;4:1-5. doi: 10.1200/JGO.2016.008698. Epub 2017 May 4. No abstract available.

25.

A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience.

Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S.

Breast J. 2018 Nov;24(6):1105-1108. doi: 10.1111/tbj.13140. Epub 2018 Sep 21. No abstract available.

PMID:
30240079
26.

Molecular characterization of cancers with NTRK gene fusions.

Gatalica Z, Xiu J, Swensen J, Vranic S.

Mod Pathol. 2019 Jan;32(1):147-153. doi: 10.1038/s41379-018-0118-3. Epub 2018 Aug 31.

PMID:
30171197
27.

Co-Incidence of Epstein-Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women.

Al-Thawadi H, Ghabreau L, Aboulkassim T, Yasmeen A, Vranic S, Batist G, Al Moustafa AE.

Front Oncol. 2018 Jul 2;8:250. doi: 10.3389/fonc.2018.00250. eCollection 2018.

28.

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies.

Willenbacher W, Seeber A, Steiner N, Willenbacher E, Gatalica Z, Swensen J, Kimbrough J, Vranic S.

Int J Mol Sci. 2018 Jul 18;19(7). pii: E2087. doi: 10.3390/ijms19072087. Review.

29.

Epstein-Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial-Mesenchymal Transition and Cancer Progression.

Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Al Moustafa AE.

Front Oncol. 2018 May 1;8:111. doi: 10.3389/fonc.2018.00111. eCollection 2018. Review.

30.

Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact?

Akhtar S, Vranic S, Cyprian FS, Al Moustafa AE.

Front Oncol. 2018 Apr 20;8:123. doi: 10.3389/fonc.2018.00123. eCollection 2018. Review.

31.

The Role of Epstein-Barr Virus in Cervical Cancer: A Brief Update.

Vranic S, Cyprian FS, Akhtar S, Al Moustafa AE.

Front Oncol. 2018 Apr 17;8:113. doi: 10.3389/fonc.2018.00113. eCollection 2018. Review.

32.

Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.

Gatalica Z, Xiu J, Swensen J, Vranic S.

Eur J Cancer. 2018 May;94:179-186. doi: 10.1016/j.ejca.2018.02.021. Epub 2018 Mar 20.

33.

Composition of the immune microenvironment differs between carcinomas metastatic to the lungs and primary lung carcinomas.

Senarathne W, Vranic S, Xiu J, Rose I, Gates P, Gatalica Z.

Ann Diagn Pathol. 2018 Apr;33:62-68. doi: 10.1016/j.anndiagpath.2017.12.004. Epub 2017 Dec 13.

34.

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.

Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S.

PLoS One. 2018 Jan 11;13(1):e0191244. doi: 10.1371/journal.pone.0191244. eCollection 2018.

35.

Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses.

Vranic S, Rodrigues AF, Buggio M, Newman L, White MRH, Spiller DG, Bussy C, Kostarelos K.

ACS Nano. 2018 Feb 27;12(2):1373-1389. doi: 10.1021/acsnano.7b07734. Epub 2018 Jan 31.

PMID:
29286639
36.

Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.

Imamovic D, Vranic S.

Ann Transl Med. 2017 Dec;5(23):467. doi: 10.21037/atm.2017.09.32. No abstract available.

37.

The role of the Hedgehog signaling pathway in cancer: A comprehensive review.

Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L.

Bosn J Basic Med Sci. 2018 Feb 20;18(1):8-20. doi: 10.17305/bjbms.2018.2756. Review.

38.

Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas.

Kardum V, Karin V, Glibo M, Skrtic A, Martic TN, Ibisevic N, Skenderi F, Vranic S, Serman L.

Ann Diagn Pathol. 2017 Dec;31:45-49. doi: 10.1016/j.anndiagpath.2017.07.002. Epub 2017 Jul 15.

PMID:
29146058
39.

Microsatellite instability status predicts response to anti-PD-1/PD-L1 therapy regardless the histotype: A comment on recent advances.

Vranic S.

Bosn J Basic Med Sci. 2017 Aug 20;17(3):274-275. doi: 10.17305/bjbms.2017.2366. No abstract available.

40.

Negative regulators of Wnt signaling pathway SFRP1 and SFRP3 expression in preterm and term pathologic placentas.

Zmijanac Partl J, Karin V, Skrtic A, Nikuseva-Martic T, Serman A, Mlinarec J, Curkovic-Perica M, Vranic S, Serman L.

J Matern Fetal Neonatal Med. 2018 Nov;31(22):2971-2979. doi: 10.1080/14767058.2017.1359830. Epub 2017 Aug 7.

PMID:
28738713
41.

The Most Frequent Isolates from Outpatients with Urinary Tract Infection.

Vranic SM, Zatric N, Rebic V, Aljicevic M, Abdulzaimovic A.

Mater Sociomed. 2017 Mar;29(1):17-20. doi: 10.5455/msm.2017.29.17-20.

42.

The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.

Kővári B, Vranic S, Marchio C, Sapino A, Cserni G.

Hum Pathol. 2017 Jun;64:164-170. doi: 10.1016/j.humpath.2017.03.026. Epub 2017 Apr 21.

43.

Long-term outcome of GIST patients treated with delayed imatinib therapy.

Kurtovic-Kozaric A, Kugic A, Hasic A, Beslija S, Ceric T, Pasic A, Vranic S, Kopric D, Iljazovic E, Todorovic Barbuscia J, Kozaric M, Ibisevic N, Keskic L, Kurtovic S.

Eur J Cancer. 2017 Jun;78:118-121. doi: 10.1016/j.ejca.2017.03.024. Epub 2017 Apr 21. No abstract available.

PMID:
28437709
44.

Whorling cellular perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma.

Michal M, Kazakov DV, Agaimy A, Hosova M, Michalova K, Grossmann P, Steiner P, Skenderi F, Vranic S, Michal M.

Ann Diagn Pathol. 2017 Apr;27:74-78. doi: 10.1016/j.anndiagpath.2017.02.001. Epub 2017 Feb 2.

PMID:
28325366
45.

Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.

Skenderi F, Ulamec M, Vanecek T, Martinek P, Alaghehbandan R, Foix MP, Babankova I, Montiel DP, Alvarado-Cabrero I, Svajdler M, Dubinský P, Cempirkova D, Pavlovsky M, Vranic S, Daum O, Ondic O, Pivovarcikova K, Michalova K, Hora M, Rotterova P, Stehlikova A, Dusek M, Michal M, Hes O.

Ann Diagn Pathol. 2017 Apr;27:48-56. doi: 10.1016/j.anndiagpath.2017.01.005. Epub 2017 Jan 19.

PMID:
28325361
46.

High-Accuracy Determination of Cytotoxic Responses from Graphene Oxide Exposure Using Imaging Flow Cytometry.

Vranic S, Kostarelos K.

Methods Mol Biol. 2017;1570:287-300. doi: 10.1007/978-1-4939-6840-4_20.

PMID:
28238145
47.

Antibiotic Resistance in Urinary Isolates of Escherichia coli.

Abduzaimovic A, Aljicevic M, Rebic V, Vranic SM, Abduzaimovic K, Sestic S.

Mater Sociomed. 2016 Dec;28(6):416-419. doi: 10.5455/msm.2016.28.416-419.

48.

Water-based and biocompatible 2D crystal inks for all-inkjet-printed heterostructures.

McManus D, Vranic S, Withers F, Sanchez-Romaguera V, Macucci M, Yang H, Sorrentino R, Parvez K, Son SK, Iannaccone G, Kostarelos K, Fiori G, Casiraghi C.

Nat Nanotechnol. 2017 May;12(4):343-350. doi: 10.1038/nnano.2016.281. Epub 2017 Jan 30.

PMID:
28135260
49.

Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers.

Vranic S, Feldman R, Gatalica Z.

Bosn J Basic Med Sci. 2017 Feb 21;17(1):9-11. doi: 10.17305/bjbms.2016.1811. Review.

50.

An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Dzinic SH, Bernardo MM, Li X, Fernandez-Valdivia R, Ho YS, Mi QS, Bandyopadhyay S, Lonardo F, Vranic S, Oliveira DS, Bonfil RD, Dyson G, Chen K, Omerovic A, Sheng X, Han X, Wu D, Bi X, Cabaravdic D, Jakupovic U, Wahba M, Pang A, Harajli D, Sakr WA, Sheng S.

Cancer Res. 2017 Feb 15;77(4):886-896. doi: 10.1158/0008-5472.CAN-16-2219. Epub 2016 Dec 6.

Supplemental Content

Loading ...
Support Center